![Richard Margolin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Margolin
Directeur/Membre du Conseil chez
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Fortune : - $ au 31/05/2026
Profil
Richard A. Margolin is the founder of CNS Research, Inc., founded in 2018.
Current jobs include Independent Director at Reviva Pharmaceuticals Holdings, Inc. since 2020 and Chief Medical Officer at TauC3 Biologics Ltd. since 2023.
Former jobs include Executive Director-Internal Medicine Research Unit at Pfizer Inc. from 2016 to 2018, Vice President-Clinical Development at Cerespir, Inc. from 2013 to 2016, and Chief Medical Officer at Eikonizo Therapeutics, Inc. from 2020 to 2023.
Education includes a doctorate from the University of California, Irvine and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Richard Margolin
| Sociétés | Poste | Début |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 14/12/2020 |
TAUC3 Biologics Ltd.
 TAUC3 Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a research and experimental development on natural sciences & engineering | Directeur Technique/Scientifique/R&D | 01/08/2023 |
Anciens postes connus de Richard Margolin
| Sociétés | Poste | Fin |
|---|---|---|
Eikonizo Therapeutics, Inc.
 Eikonizo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops disease-modifying therapies to improve the lives of people by neurodegenerative, cardiorenal and other diseases | Directeur Technique/Scientifique/R&D | 01/12/2023 |
| PFIZER INC. | Corporate Officer/Principal | 01/04/2018 |
Cerespir, Inc.
 Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Develops molecules for the treatment of Alzheimer disease | Corporate Officer/Principal | 01/12/2016 |
CNS Research, Inc.
 CNS Research, Inc. Internet Software/ServicesTechnology Services Operates online websites which provides neurologists & medication services through research with pharmaceutical companies | Fondateur | - |
Formation de Richard Margolin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Develops molecules for the treatment of Alzheimer disease | Health Technology |
Eikonizo Therapeutics, Inc.
Eikonizo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops disease-modifying therapies to improve the lives of people by neurodegenerative, cardiorenal and other diseases | Health Technology |
TAUC3 Biologics Ltd.
TAUC3 Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a research and experimental development on natural sciences & engineering | Commercial Services |
CNS Research, Inc.
CNS Research, Inc. Internet Software/ServicesTechnology Services Operates online websites which provides neurologists & medication services through research with pharmaceutical companies | Technology Services |
Reviva Pharmaceuticals Holdings, Inc.
 Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
